Hengrui Medicine: Director Sun Jieping plans to reduce the company's shares by no more than 476,700 shares.

Hengrui Medicine announced that Sun Jieping, a director and senior vice president of the company, plans to reduce his holdings of the company's shares through centralized bidding transactions, with a total reduction of no more than 47,670 shares, accounting for 0.007% of the company's total share capital.